ArticleIndian journal of ophthalmology2021
Avoiding predatory publishing for early-career ophthalmologists.
Article in Indian journal of ophthalmology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed.
- The academic impact of Open Science: a scoping review.Royal Society open science · 2025Review
- An Analysis of Solicitations From Predatory Journals in Ophthalmology.American journal of ophthalmology · 2024Article
- Predatory journals: The dark side of publications.Indian journal of ophthalmology · 2022Article
- Commentary: Paradigm shift in scientometric indices and publication policies of various ophthalmology journals.Indian journal of ophthalmology · 2022Article
- Comment on: Predatory publications - Recognize and avoid.Indian journal of ophthalmology · 2022Article
- Publication addiction during COVID-19 pandemic - A rising boon or a bane.Indian journal of ophthalmology · 2022Article
- Predatory publications - Recognize and avoid.Indian journal of ophthalmology · 2021Article
- Commentary: Avoiding predatory publishing for early career ophthalmologists.Indian journal of ophthalmology · 2021Article
- Commentary: Publish or perish - Musings of a young faculty.Indian journal of ophthalmology · 2021Article
Corrections and comments
- Commented on by
- Commented on by
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This article aims at analyzing the impact of predatory publishing in ophthalmology, criteria to identify a legitimate journal, red flags of a predatory journal, sources, and checkpoints available before publishing scientific work in a standard ophthalmology journal. A retrospective review was performed and a list of suspected Ophthalmology predatory journals was extracted through four major so-called blacklists: Beall's, Cabell's, Manca's, and Strinzel's list. This list of journals was then cross-referenced with the UGC CARE and vetted whitelist of vision science journals to remove the legitimate journals. Moreover, as all the predatory journals are supposed to be open access, all possible types of open-access journals on the Scimago webpage were also searched. A gross estimate in terms of publication cost was searched for, and a list of authentic links to find out a legitimate journal was prepared. Additionally, the methodology by which these predatory journals penetrate legitimate indexes such as PubMed was also evaluated. A total of 51 ophthalmology predatory journals were enlisted. Thirty-eight out of 124 Ophthalmology journals listed on Scimago were open access, and the cost of publishing in predatory journals ranged from USD50-500, which is substantially lower than that in legitimate journals (USD 50-3000). A total of 13 open-access platforms exist, with 10 characteristic red flags to identify a predatory journal. These journals have penetrated legitimate indexes such as PubMed by similar-sounding names to the legitimate journals and have published articles with external funding, which needs indexing. Predatory publishing impacts the quality of research in every field, including Ophthalmology, and must be discouraged.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.